Quotes

Back To Menu

Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

Invest

19 Oct 2018 | 11:05 AM

1,422.00
-27.00 (-1.86%)

  • Outperforms Index

    16.88%

    Return (1Y)

    Beaten S&P BSE Healthcare by 14.39%

  • More Volatile

    1.61%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.51%

  • Not so consistent

    6/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,812

1,812.00

1,020

1,020.00

News & Announcements

  • GlaxoSmithKline Pharmaceuticals announces board meeting date

    20 days ago

  • Glaxosmithkline Pharmaceuticals fixes record date for bonus issue

    55 days ago

  • Glaxosmithkline Pharmaceuticals standalone net profit rises 235.31% in the June 2018 quarter

    85 days ago

  • Board of Glaxosmithkline Pharmaceuticals recommends bonus issue of 1:1

    86 days ago

Price vs Volume

Stock Trivia

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -8.51% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -17.4% since past 1 Year

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 35.47% since past 1 Year

  • Glaxosmithkline Pharma Ltd has the 3rd highest P/Bratio according to FY201803 data among stocks in Pharmaceuticals Sector

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...